Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Jonestrading 

Purple Biotech Ltd. ADR diskutieren

Purple Biotech Ltd. ADR

WKN: A2QLTP / Symbol: PPBT / Name: Purple Biotech / Aktie / Biotechnologie & medizinische Forschung / Micro Cap /

0,48 €
3,36 %

Einschätzung Buy
Rendite (%) -55,45 %
Kursziel 7,19
Veränderung
Endet am 21.07.24

Purple Biotech Ltd. (NASDAQ: PPBT) is now covered by analysts at Jonestrading. They set a "buy" rating and a $8.00 price target on the stock.
Ratings data for PPBT provided by MarketBeat

Einschätzung Buy
Rendite (%) -49,32 %
Kursziel 9,16
Veränderung
Endet am 21.11.24

Purple Biotech Ltd. (NASDAQ: PPBT) had its price target raised by analysts at HC Wainwright from $9.00 to $10.00. They now have a "buy" rating on the stock.
Ratings data for PPBT provided by MarketBeat

Einschätzung Buy
Rendite (%) -23,78 %
Kursziel 9,21
Veränderung
Endet am 27.02.25

Purple Biotech Ltd. (NASDAQ: PPBT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Ratings data for PPBT provided by MarketBeat

Einschätzung Buy
Rendite (%) -37,43 %
Kursziel 9,21
Veränderung
Endet am 05.03.25

Purple Biotech Ltd. (NASDAQ: PPBT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Ratings data for PPBT provided by MarketBeat

Einschätzung Buy
Rendite (%) 7,88 %
Kursziel 9,34
Veränderung
Endet am 26.04.25

Purple Biotech Ltd. (NASDAQ: PPBT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Ratings data for PPBT provided by MarketBeat